Annual Review 2014

30 years closer to a cure

This year we pushed the boundaries of our translational research further than ever before.

erin griffin

During our 30th year, Children's Cancer Institute attracted record levels of peer-reviewed grant funding and fundraising support, entered into a greater number and breadth of partnerships and pushed the boundaries of our translational research further than ever before. Truly a ground-breaking year!

Our 2014 highlights include:

  • We launched an international clinical trial for children with high-risk neuroblastoma at Sydney Children’s Hospital, Randwick
  • Based on our research success we attracted our highest ever level of grant funding from the government, including a very competitive Program Grant from the National Health & Medical Research Council
  • The single largest funding contribution ever made to childhood cancer research in Australia was delivered by the Cancer Therapeutics Cooperative Research Centre (CTx), which helped us kick-start our ground-breaking new Personalised Medicine Program for children with high-risk cancer
  • We played a leading role the establishment of Paediatrio, a partnership between Sydney Children’s Hospitals Network, Children’s Medical Research Institute and Children’s Cancer Institute to improve health outcomes for children in NSW.
  • We launched the Centre for Childhood Cancer Research in partnership with UNSW Australia
  • We introduced a new brand to celebrate 30 years since our lab doors opened
  • We welcomed 36,000 new donors who joined our cause
  • We set wheels spinning with our first Endure for a Cure cycling challenge and broke new ground with our Build for a Cure campaign, which together raised more than $973,000
  • We achieved our highest ever level of fundraising income